Last deal

$2M
Local Amount - EUR 2.2M

Amount

Seed

Stage

13.06.2022

Date

2

all rounds

$2M

Total amount

General

About Company
A new technology to analyse Parkinson's disease symptoms is being developed by Adamant Health.

Industry

Sector :

Subsector :

Keywords :

founded date

24.08.2020

Number of employees

Company Type

For Profit

Last funding type

Seed

IPO status

Private

Description

The company specialises in providing motion and EMG measurement and analysis services for people with movement disorders like Parkinson's disease, using wearable sensors to measure neuromuscular function and motor symptoms in a home environment. This allows medical professionals to track patients' real motor symptoms during their daily life, determine the status of the disease and the effectiveness of the treatment. The technology is also beneficial for academic research teams and pharmaceutical companies developing new treatments or medications for various movement disorders, based on over 15 years of research at the University of Eastern Finland.